These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1460163

  • 1. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 2. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 3. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.
    Shapira B, Lerer B, Kindler S, Lichtenberg P, Gropp C, Cooper T, Calev A.
    Br J Psychiatry; 1992 Feb; 160():223-9. PubMed ID: 1540763
    [Abstract] [Full Text] [Related]

  • 4. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
    Mannel M, Müller-Oerlinghausen B, Czernik A, Sauer H.
    J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
    [Abstract] [Full Text] [Related]

  • 5. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 6. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Aug; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 7. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Aug; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 8. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH, Dinan TG.
    Biol Psychiatry; 1995 Mar 15; 37(6):364-8. PubMed ID: 7772644
    [Abstract] [Full Text] [Related]

  • 9. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS, Lecić D, Doder M, Marinković J, Filipović S.
    Biol Psychiatry; 1996 Oct 15; 40(8):769-75. PubMed ID: 8894070
    [Abstract] [Full Text] [Related]

  • 10. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ, Murray RM, O'Keane V.
    Biol Psychiatry; 1998 Oct 01; 44(7):555-61. PubMed ID: 9787879
    [Abstract] [Full Text] [Related]

  • 11. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge.
    Gerra G, Fertonani G, Tagliavini P, Zaimovic A, Delsignore R, Maestri D, Avanzini P, Caccavari R, Brambilla F.
    Psychiatry Res; 1995 Sep 29; 58(2):153-60. PubMed ID: 8570767
    [Abstract] [Full Text] [Related]

  • 12. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ, McTavish SF, Park SB, Cowen PJ.
    Br J Psychiatry; 1995 Aug 29; 167(2):238-42. PubMed ID: 7582676
    [Abstract] [Full Text] [Related]

  • 13. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J, Toll C, Schonlau P, Rohrmann S, Netter P.
    Neuropsychobiology; 2000 Aug 29; 41(1):38-47. PubMed ID: 10629434
    [Abstract] [Full Text] [Related]

  • 14. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May 29; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 15. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S.
    Life Sci; 1984 Mar 12; 34(11):1029-39. PubMed ID: 6700367
    [Abstract] [Full Text] [Related]

  • 16. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May 12; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 17. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM, Ware CJ, da Roza Davis JM, Cowen PJ.
    Br J Psychiatry; 1992 Mar 12; 160():372-8. PubMed ID: 1562864
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM, Pasatiempo AP, Yeung J, Cooper TB, Bridger WH, Rabinovich H.
    Psychiatry Res; 1992 Sep 12; 43(3):263-76. PubMed ID: 1438624
    [Abstract] [Full Text] [Related]

  • 19. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct 12; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 20. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.
    O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG.
    Br J Psychiatry; 1992 May 12; 160():643-6. PubMed ID: 1591573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.